Lv1
67 积分 2021-07-20 加入
PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer
1个月前
已完结
CRTAM inhibition mitigates toxicity of immune checkpoint inhibitors without antitumor efficacy trade-off
1个月前
已完结
ERBB2-Activating Mutations and Co-Occurring Genomic Alterations Contribute to Disease Heterogeneity in Patients With ERBB2-Mutant Lung Cancer
2个月前
已完结
EGFR-TKI plus chemotherapy versus tki monotherapy in advanced EGFR-Mutant NSCLC with high PD-L1 expression: a real-world retrospective study
2个月前
已完结
Medication guide for the perioperative management of oral antineoplastic agents in cancer patients
3个月前
已完结
Scoring Reliability of c-Met Immunohistochemical Assays in Lung Adenocarcinoma
6个月前
已完结
Microbial metabolite FAD mobilizes adipocyte lipid remodeling to enhance cancer immunotherapy efficacy
8个月前
已关闭
Integrative spatial analysis reveals tumor heterogeneity and immune colony niche related to clinical outcomes in small cell lung cancer
9个月前
已完结
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
11个月前
已完结
EGFR-Mutant NSCLC: Chemo–TKI Bests TKI
11个月前
已完结